Aims High-(HR) and intermediate-high risk (IHR) pulmonary embolisms (PEs) are related to
high early mortality and long-term sequelae. We aimed to describe clinical outcomes and …

* Division of Anesthesia and Critical Care Medicine, Mayo Clinic, Rochester, MN y Division
of Critical Care Medicine, Mayo Clinic, Rochester, MN z Department of Anesthesiology and …

Abstract Background and Aims Catheter-based therapies (CBTs) have been developed as a
treatment option in patients with pulmonary embolism (PE). There remains a paucity of data …

Pulmonary embolism (PE) remains both difficult to diagnose and complex to treat despite
over 50 years of recognition as a cause of significant morbidity and mortality. 1 Behind …

Purpose Intermediate-high-risk pulmonary embolism (IHR PE) is a challenging form of
embolism obstruction that causes right ventricular (RV) dysfunction. The optimal …

Background Cancer patients are at risk of pulmonary embolism (PE). Catheter-based
therapies (CBT) are novel reperfusion options for PE though data in patients with cancer is …

Background: Systemic thrombolysis (ST) is the guideline-recommended treatment for high-
risk pulmonary embolism (PE), although catheter-directed thrombolysis (CDT) may provide a …

Objective To examine the characteristics and outcomes among patients with high-risk
pulmonary embolism (PE) and malignancy. Patients and Methods The Nationwide …

Background: For patients with high-risk pulmonary artery embolism (PE), catheter-directed
therapies pose a viable alternative treatment option to systemic thrombolysis or …

La tromboembolia pulmonar (TEP) continúa siendo la tercera causa de muerte de origen
vascular en Espana 1. La fibrinólisis sistémica (FS) es la primera línea de tratamiento en …